Jane Street’s Liminatus Pharma Warrants LIMNW Stock Holding History

Jane Street’s Portfolio LIMNW Stock Details LIMNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.34K	Sell	24,126 -148	-0.6%	-$8	﹤0.01%	11463
2026 Q2	$1.82K	Hold	24,274	–	–	﹤0.01%	11366
2026 Q1	$971	Hold	24,274	–	–	﹤0.01%	11392
2025 Q4	$850	Sell	24,274 -153	-0.6%	-$15	﹤0.01%	10935
2025 Q3	$3.61K	Sell	24,427 -2,516	-9%	-$491	﹤0.01%	10618
2025 Q2	$6.46K	Buy	+26,943	New	+$5.29K	﹤0.01%	9429

Other funds holding LIMNW

MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return

Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $200M AUM 6.35% 1-Year Est. Return

Flow Traders U.S. New York $4.12B AUM 34.04% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $14.8M AUM 14.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jane Street's LIMNW Position: Q3 2026 in Review

Jane Street reduced its Liminatus Pharma Warrants (LIMNW) stake by 0.61% in Q3 2026, selling an estimated $8 and leaving 24,126 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #11463.

Jane Street first reported a position in LIMNW in Q2 2025 and has held it in 6 quarters since. The position peaked at $6.46K in Q2 2025. 9 funds tracked by Wall St. Rank hold LIMNW as of Q3 2026.

Jane Street held 24,126 shares of Liminatus Pharma Warrants worth $1.34K as of Q3 2026.
Jane Street sold 148 Liminatus Pharma Warrants shares in Q3 2026, an estimated $8.
Liminatus Pharma Warrants made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11463 holding.
Jane Street first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 6 quarters since.
Jane Street's Liminatus Pharma Warrants position peaked at $6.46K in Q2 2025.
9 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.